Bioline AgroSciences Ltd Overview
Bioline AgroSciences is a specialist producer of macro-organisms — predatory mites, parasitoid wasps, predatory bugs, lacewings and beneficial nematodes — used by growers of protected vegetables, soft fruit, ornamentals and cut flowers in place of chemical insecticides. With roots in a 1979 Essex start-up and in the French Trichogramma pioneer Biotop, it spent 23 years inside Ciba, Novartis and Syngenta and nine years inside the French cooperative group InVivo before a private equity carve-out in February 2025. French financial press ranks it third globally in macrobials, behind Koppert and Biobest. Its differentiation is application technology rather than species discovery: the patented Bugline continuous sachet, Gemini sachets, Trichogramma dispensers and the Sprayvent liquid-phase mite sprayer. Under Eurazeo it is pursuing a buy-and-build strategy, with the Belgian aphid-parasitoid producer Viridaxis acquired in September 2025, and a stated ambition of 13–15% annual organic growth.
The company's own description
The company does not publish an annual report with a narrative business description. Its consistent public self-description, used across recruitment pages and trade directories, is that it produces and markets a wide range of invertebrate biological control organisms used to control insect pests in a variety of crops, that it is active in around 30 countries with particular strength in Europe and North America, and that its primary target crops are protected vegetables, ornamentals, soft fruits and berries. The January 2026 leadership announcement described it as an international company operating in six countries, specialising in the development, production and commercialisation of biological crop protection and biocontrol solutions.
Independent characterisation
Bioline is a biological manufacturing business. It mass-rears living organisms in controlled-environment "biofactories", formulates them into delivery formats, and ships them through a short, chilled supply chain to growers. Three features define the model.
First, the product is perishable and seasonal. Beneficial organisms have a shelf life measured in days, and demand is concentrated in crop-establishment windows. The current CEO has publicly identified demand spikes — citing Spain, where demand surges at one point in the season and then falls away — as a core operational challenge, with the aim of balancing spikes at a global level (HortiDaily, June 2026).
Second, value is added in the delivery system as much as in the organism. Many species sold by Bioline are also sold by competitors. What differs is how the organism reaches the crop: slow-release sachets, sachets on sticks for propagation trays, a continuous sachet ribbon that can be laid mechanically along crop rows, blister packs with no carrier material, drone-broadcast capsules and a sprayer that applies predatory mites in liquid. The CEO has described the strategy as being a fast follower on new species and a leader in application technology.
Third, sales are a mix of direct and distributor. In North America product is sold through horticultural distributors (Griffin Greenhouse Supplies lists Bioline lines under Bioline's own vendor codes). In Spain the company sells through its Almería subsidiary Bioline Iberia and, since October 2025, through a collaboration with the Unica Group cooperative. Sprayvent was launched "through partner distributors".
Revenue model
| Revenue type | Presence | Comment |
|---|---|---|
| Product sales (living organisms in delivery formats) | Core, overwhelming majority | Recurring by nature — growers re-order every crop cycle |
| Application equipment (Sprayvent sprayer and similar) | Emerging | Pricing model not disclosed |
| Technical advice and crop programmes | Bundled with product | Delivered by technical advisers and a Bioline app for release rates; no separate fee disclosed |
| Pollination and sundries | Minor | Listed in the company's IPM Essen exhibitor profile |
| Licensing or subscription | None disclosed | — |
The product/service split is not publicly disclosed.
Value chain position and customers
Bioline sits upstream as a primary producer and brand owner. Its customers are commercial growers (greenhouse vegetables, strawberries and other berries, cut flowers, pot plants, nursery stock, medicinal crops), grower cooperatives, and horticultural distributors. Through the Biotop heritage it also serves maize growers with Trichogramma against corn borer, and a hobby-gardener range. Through Dudutech in Kenya it serves the East African cut-flower and export vegetable industry.
Financial Narrative
Scope and caveats
Figures relate to Bioline AgroSciences Limited, the UK legal entity only, in GBP. They are drawn from aggregator summaries (Endole, GlobalDatabase) of the full accounts filed at Companies House, because the filings themselves could not be opened. Fiscal periods are irregular:
Income statement
Sources: revenue FY2024 and YoY change — Endole; FY2023 derived by subtraction; EBITDA FY2024 (GBP 566,164) — GlobalDatabase, an aggregator derivation rather than a reported line; EBITDA margin computed from those two figures. EPS is not applicable to a private single-shareholder company. Revenue CAGR cannot be computed on two data points with irregular prior periods.
Balance sheet
Sources: cash — Endole (GBP 1.36 M, up GBP 10 K). Share capital — Companies House SH01 (the allotment took place in September 2023, i.e. within FY2024). GlobalDatabase's statement of a 99.76% cash increase conflicts with Endole's 0.7% and appears to be a data error; Endole's figure is used.
Cash flow and ratios
ROE, ROA, ROIC, current ratio, debt/equity, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle cannot be computed from the data retrieved and are not publicly disclosed in accessible form.
Group-level indicators
Aggregator revenue "estimates" for the group vary widely (ZoomInfo and Datanyze USD 21.9 M; RocketReach USD 5.9 M) and are modelled values, not disclosures. They conflict with the EUR 50 M press figure and are disregarded.
Commentary
The UK entity is small relative to the group — roughly a quarter to a third of group revenue on the available figures, though the exact share cannot be stated because inter-company sales are not visible. Three observations follow from the limited data.
Turnover is recovering. Endole notes that turnover had been falling and has risen in the last two years. A 5.9% increase in FY2024 on a headcount that fell 8% lifted revenue per employee from about GBP 135 K to about GBP 156 K, which suggests productivity gains or a shift in where production sits within the group.
Profitability at the UK entity is thin. An EBITDA of about GBP 0.57 M on GBP 14.35 M of turnover is a margin near 4%. Dealroom's margin series for earlier years shows a decline from mid-teens EBITDA margins in 2016–2019 to negative margins in 2021–2022. Dealroom labels these as estimates, so they are indicative only, but the direction is consistent with the cost inflation in energy, labour and freight that affected all glasshouse-based production in that period.
The September 2023 share allotment, accompanied by a change to the articles, indicates a recapitalisation by the then parent roughly seventeen months before the sale.
7. SEGMENTAL AND GEOGRAPHIC REVENUE MAPPING
Geographic revenue is not publicly disclosed in any source retrieved. UK statutory accounts normally include a turnover-by-destination note; that note sits in the filings that could not be opened.
Qualitative geographic picture
No basis exists for naming the fastest-growing or declining region with figures. Management commentary points to Spain as both a priority market and a source of volatility: demand spikes, and severe rain and flooding in 2026 were cited by the CEO.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Label Details
| Label | Period | Length |
|---|---|---|
FY2020 | 1 July 2019 to 30 September 2020 | 15 months |
FY2021 | 1 October 2020 to 30 September 2021 | 12 months |
FY2022 | 1 October 2021 to 30 June 2022 | 9 months |
FY2023 | 1 July 2022 to 30 June 2023 | 12 months |
FY2024 | 1 July 2023 to 30 June 2024 | 12 months |
Next | 1 July 2024 to 31 December 2025 | 18 months, not yet shown as filed |
Income Statement and Margin Analysis (%)
| Metric | FY2023 | FY2024 |
|---|---|---|
Revenue (GBP Mn) | 13.55 | 14.35 |
Revenue YoY growth (%) | — | 5.9 |
EBITDA (GBP Mn) | — | 0.57 |
EBITDA margin (%) | — | 3.9 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansKey Financials
| Metric | FY2023 | FY2024 |
|---|---|---|
Cash and equivalents (GBP Mn) | 1.35 | 1.36 |
Share capital (GBP Mn) | — | 3.11 |
Operating Metrics (number) and Income Statement
| Metric | FY2023 | FY2024 |
|---|---|---|
Employees, UK entity (number) | 100 | 92 |
Revenue per employee (GBP K) | 135.5 | 156.0 |
Financial Analysis
| Indicator | Value | Period | Source |
|---|---|---|---|
Group revenue | About EUR 50 M | At the February 2025 transaction | CFNews |
Group revenue growth | Double-digit growth since 2018 | 2018–2024 | Eurazeo press release |
Organic growth target | 13–15% per year | Forward-looking | CEO interview, HortiDaily, June 2026 |
Region Overview
| Region | Presence | Direction | Evidence |
|---|---|---|---|
North Europe (UK, Netherlands, Germany, Scandinavia) | Home market; active trade-fair presence at IPM Essen and HortiContact Gorinchem with a Dutch commercial contact | Stable, competitive — this is the home ground of Koppert and Biobest | HortiDaily, 2026 |
South Europe (Spain, France, Italy) | Almería biofactory; French Trichogramma base; Italian-language marketing | Investment focus — Unica agreement in October 2025 | HortiDaily |
North America | California production; distributor network; Mexico and Canada entities | Established; soft fruit and ornamentals emphasis | Company timeline; Griffin |
Africa and Middle East | Dudutech, Kenya | Largest share of workforce — Revelio Labs places about half of tracked staff in Sub-Saharan Africa | Revelio Labs |
Capital Markets
| Item | Position |
|---|---|
Share price performance, 1/3/5-year | Not applicable — no listed equity |
P/E, EV/EBITDA, EV/Sales, P/B | Not applicable; transaction multiples undisclosed |
Listed debt | None identified |
Filing of accounts to 31 December 2025 | First financial data under Eurazeo; 18-month period; reveals debt, margin and any goodwill |
PSC and confirmation statement detail | Confirms holding structure and control |
Clarification of Ludwik Pokorny's role | Continuity of customer relationships and M&A leadership |
Second add-on acquisition | Tests the pace of buy-and-build |
EPBF final close (target September 2026) | Indicates capital available for follow-on investment |
Sprayvent adoption data | Tests the core differentiation claim |
2026–27 Spanish season | Volume through Unica; recovery from flooding |
New auditor's identity and opinion | Quality of financial reporting after carve-out |
Owner by Period
| Period | Owner |
|---|---|
1979–1992 | Bunting family |
1992–1996 | Ciba-Geigy |
1996–2000 | Novartis |
2000–2016 | Syngenta |
2016–2025 | InVivo (with LFPI, IDIA and Unigrains at holding level from 2018) |
2025– | Eurazeo Planetary Boundaries Fund (majority), Aurae (minority) |
Source Details
| Source | Type | Used for |
|---|---|---|
Companies House, company 02305412 (overview, officers, filing history) | Primary register | Legal status, names, dates, directors, filings, capital |
Eurazeo press release, 3 March 2025 | Shareholder disclosure | Ownership, strategy, growth since 2018 |
InVivo press releases, 29 February 2016 and February 2021 | Former shareholder disclosure | 2016 acquisition, Dudutech |
Company press releases via Greenhouse Grower, New AG International, HortiDaily, Vertical Farm Daily, Hortibiz | Company statements in trade press | Leadership, Viridaxis, Sprayvent, Unica, product launches |
HortiDaily CEO interview, 18 June 2026 | Management interview | Strategy, growth target, operations |
CFNews, Option Droit & Affaires, Agrodistribution, Agro Matin, Terre-net, Vivien & Associés | French financial and trade press | Group revenue, rank, headcount, site count, entities, deal structure |
Company "About us" timelines (North America, Iberia) | Company website | Corporate history |
Endole, GlobalDatabase | Aggregators of statutory accounts | UK-entity turnover, cash, employees, EBITDA |
PitchBook, Mergr, CB Insights, Dealroom, Revelio Labs, LeadIQ, ZoomInfo, RocketReach | Data aggregators | Deal dates, patent count, workforce estimates (conflicts noted) |
Griffin Greenhouse Supplies, EcophytoPIC product sheet, University of Hertfordshire AERU, IPM Essen exhibitor listing, Eurofresh Distribution | Distributor, regulatory and trade listings | Product specifications and formats |
Mordor Intelligence, Fortune Business Insights, Kings Research | Market research summaries | Market size and structure |
Executive Leadership
Executive Leadership Team
| Name | Title | Since | Background | Source |
|---|---|---|---|---|
Gerry Huygens | Chief Executive Officer | 5 January 2026 | Economist by training; career at AB InBev and Mars; leadership roles at Aveve and Biobest | Company press release; HortiDaily |
Ludwik Pokorny | Executive Chairman of the Board (announced January 2026); previously CEO | Director of the UK entity from June 2018 to June 2026 | Led the business through the InVivo period and the Eurazeo carve-out; French national, born November 1966 | Company press release; Companies House |
Benoit Genot | Chief Marketing and Innovation Officer | September 2025 | Leads global marketing and innovation | Greenhouse Management; 2B Monthly |
María José Pardo | Manager, Bioline Iberia | Not stated | — | Eurofresh Distribution |
Hans van de Pas | Commercial contact, Netherlands | Not stated | — | HortiDaily |
Ronald Valentin | — | Not stated | — | HortiDaily |
Board of Directors
| Director | Status | Appointed | Resigned | Note |
|---|---|---|---|---|
"Gerry Leslie" (Belgian, born April 1972, resident in Belgium) | Active — sole current director | 9 June 2026 | — | See discrepancy note |
Ludwik Pokorny | Resigned | 29 June 2018 | 20 June 2026 | — |
Laurent Martel | Resigned | 15 March 2016 | 27 February 2025 | InVivo nominee |
Maryline Danzel d'Aumont | Resigned | 17 April 2023 | 27 February 2025 | InVivo nominee |
Maha Fournier | Resigned | 15 March 2016 | 17 April 2023 | InVivo nominee |
Eriska Secretaries Limited (company secretary) | Resigned | 15 March 2016 | 27 February 2025 | No replacement secretary shown |
Directors' Remuneration
| Item | Position |
|---|---|
Chair/CEO separation | Separated from 5 January 2026 by announcement |
Independent directors | None identifiable at the UK entity |
Executive compensation | Not publicly disclosed. No proxy statement exists |
Shareholders | EPBF majority, Aurae minority; percentages not disclosed. Management participation not disclosed |
Sponsor leads | Wilfried Piskula and Erwann Le Ligné, partners and co-heads of EPBF, under Sophie Flak of the Eurazeo executive board |
Governance Timeline
| Date | Initiative | Type | Source |
|---|---|---|---|
Jan 2025 | Sprayvent launch | Product and platform | Company news |
Feb 2025 | Change of ownership to EPBF and Aurae | Capital and ownership | Eurazeo |
Jun 2025 | Move to a December year end | Finance | Companies House |
Sep 2025 | Viridaxis acquisition | M&A | New AG International |
Sep 2025 | Creation of a combined marketing and innovation executive role | Organisation | Trade press |
Oct 2025 | Unica Group collaboration, including joint communication toward zero-residue production | Partnership | HortiDaily |
Jan 2026 | CEO/Chairman split | Governance | Company press release |
Jan–Mar 2026 | Eggline, Phytoline PURE, Podiline | Product | Trade press |
Targets & Commitments
| Target | Value | Source |
|---|---|---|
Organic revenue growth | 13–15% per year | CEO, HortiDaily, June 2026 |
Emissions or ESG targets | Not publicly disclosed at company level | — |
Cost programme with quantified target | None disclosed | — |
Competitive Landscape
Key Competitors
| Competitor | Country | Ownership | Overlap with Bioline | Relative position |
|---|---|---|---|---|
Koppert | Netherlands | Family-owned | Full macrobial range, pollination, microbials | Global number one; much larger and broader |
Biobest Group | Belgium | Private, investor-backed | Full macrobial range, pollination, monitoring, biopesticides | Global number two; acquisitive. Owns Beneficial Insectary. Bioline's CEO is a Biobest alumnus |
BioBee | Israel | Kibbutz-owned | Predatory mites, pollination | Strong in Mediterranean and Latin America |
Agrobío | Spain | Private | Mites, bumblebees | Direct rival in Almería |
Bioplanet | Italy | Private | Predators and parasitoids | Southern Europe |
Andermatt Group | Switzerland | Private | Macrobials and microbials | Diversified biologicals group |
Applied Bio-nomics | Canada | Private | Predatory mites and insects | North American producer |
Anatis Bioprotection | Canada | Private | Trichogramma, predators | Overlaps with Tricholine |
e-nema | Germany | Private | Entomopathogenic nematodes | Overlaps with Exhibitline |
BASF (Nemasys) | Germany | Listed | Nematodes | Major-backed nematode brand |
Arbico Organics, Rincon-Vitova, IPM Laboratories | USA | Private | Insectaries and resellers | Regional |
Kenya Biologics, Real IPM | Kenya | Private / group-owned | East African biocontrol | Overlaps with Dudutech |
Peer Comparison FY2024
| Metric | Bioline AgroSciences | Koppert | Biobest Group | BioBee |
|---|---|---|---|---|
Revenue | About EUR 50 M (group, 2025 press) | — | — | — |
Growth | Double-digit since 2018 (Eurazeo); target 13–15% | — | — | — |
Margins | UK entity EBITDA margin about 4% (FY2024, aggregator) | — | — | — |
Pollination offer | Minor | Major | Major | Major |
Microbial biopesticides | Not a focus | Yes | Yes | Limited |
“—” = not publicly disclosed.
Recent Developments
The window runs from April 2025 to October 2026. Events from January to March 2025 are included because they frame everything that follows.



